At the 2024 European Society for Radiation Oncology (ESTRO) annual meeting, Varian, a Siemens Healthineers company, will showcase its dedication to innovation in cancer care. With a focus on delivering improved outcomes for patients and care teams, Varian is working towards providing accessible, high-quality treatment options for individuals worldwide.
One of Varian’s highlighted solutions is the HyperSight imaging system, now available as an optional feature on various radiotherapy platforms. This cutting-edge technology offers superior image quality, enhanced contrast, and faster image acquisition compared to traditional imaging systems.
Additionally, Varian will introduce ARIA CORE, a next-generation oncology management solution designed to streamline oncology workflows and provide actionable analytics for more personalized care. Another innovative tool, DirectSetup Notes, allows documentation of patient setup information directly on Siemens Healthineers CT simulators, improving workflow efficiency and data transfer for future reference.
The MAGNETOM Free.Max RT Edition, an addition to Siemens Healthineers MR imaging portfolio, provides increased anatomical detail and flexibility for personalized radiation therapy at a lower cost. Meanwhile, upgrades to the IDENTIFY patient motion management system aim to optimize performance and integrate with treatment delivery processes, ensuring precise motion management during treatment.
Varian’s commitment to enhancing patient outcomes is demonstrated through its continued efforts to elevate the standard of care. By presenting evidence-based innovations at ESTRO, Varian contributes to the growing body of clinical data across various treatment domains, reinforcing its dedication to improving patient care.
As a leader in the field of cancer care, Varian, along with Siemens Healthineers, aims to empower care providers with innovative technologies and solutions to treat patients worldwide. By offering advanced imaging, radiation therapy, software, and services, Varian supports every step of the cancer care journey, from screening to survivorship.
To learn more about Varian and its commitment to fighting cancer, visit their website at http://www.varian.com. For press inquiries, please contact Kristin Corey at Varian Corporate Communications.
References:
1. IARC – https://gco.iarc.who.int
2. M Abdel-Wahab, et al. JCO Global Oncol. 2021(7):827-842.
***Third-party trademarks are the property of their respective owners.***
Source link
